Market Cap 11.14B
Revenue (ttm) 2.85B
Net Income (ttm) 426.86M
EPS (ttm) N/A
PE Ratio 18.32
Forward PE 16.89
Profit Margin 14.96%
Debt to Equity Ratio 0.00
Volume 394,519
Avg Vol 2,184,396
Day's Range N/A - N/A
Shares Out 191.78M
Stochastic %K 67%
Beta 0.17
Analysts Strong Sell
Price Target $96.50

Company Profile

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic pep...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 506 6700
Address:
770 Lindaro Street, San Rafael, United States
Quantumup
Quantumup Jul. 14 at 4:24 PM
UBS reiterated $PTCT Buy-$71 after they hosted a medical geneticist and professor of pediatrics who is an expert on PKU and treats~320 patients. $BMRN $SRPT $JNJ $BIIB NVS RHHBY LRMR RARE VRTX EWTX CAPR #KOL UBS added, "Our discussion focused on the treatment paradigm in PKU with current management options (low-Phe diet, Kuvan/sapropterin, Palnynziq) as well as $PTCT's sepiapterin (recently approved in Europe as Sephience, US FDA PDUFA 7/29). Overall, we think the call was highly supportive of a strong potential launch for $PTCT's sepiapterin. UBS went on to give Their Key Takeaways from the Expert Call (In IMAGE Below):
0 · Reply
shoagh12
shoagh12 Jul. 9 at 6:16 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 8:33 AM
$BMRN Excellent article that nails exactly where BMRN stands right now. So if you want to update your BMRN knowledge or get acquainted with BMRN, this is a must read. https://beyondspx.com/article/biomarin-strategic-transformation-fuels-profitable-growth-trajectory-bmrn
0 · Reply
dewmoore
dewmoore Jul. 8 at 2:17 PM
$KNW Reposting for all of the newbies from $BMRN and $SBET --- $SRM -- STRIPE - BANK- STABLECOINS - CREDIT CARDS --- do the math TINY FLOAT and GREG giving us $100M+ in bitcoins --- shittt this is $BMNR alll day let's GO!!!!
0 · Reply
M1Tanker
M1Tanker Jul. 7 at 9:17 PM
$NCPL $BMRN 👇👇👇
1 · Reply
Stockbricks
Stockbricks Jul. 7 at 9:04 PM
$NCPL they looped in Matt Morgan to their advisory board, like $BNRN and NCSL is just shy of 25 mil. Imagine 200-500 market cap rise could head to 100 like $BMRN imo. I I’ll load slowly
0 · Reply
HodlMaBeer
HodlMaBeer Jul. 7 at 1:55 PM
@Pika_Capital what are your thoughts on $BMRN
0 · Reply
prohibited
prohibited Jul. 7 at 1:20 AM
These stocks are my favorites for tomorrow $OST , $SONN , $BMRN Is it 4 AM YET!?
0 · Reply
Codyz28
Codyz28 Jul. 4 at 3:11 AM
$SBET I've made money on both, but SBET has a lot more shares in the float now. It's the hard truth... It definitely will go up, but the $100 price range seems unlikely with the amount of shares it has now... $100 would be above 6 billion market cap. $BKKT has my vote to reach $100 first, has only 7 million shares in the float with 35 percent owned by insiders. This is why SBET stock was able to reach $100 due to the lower float size last month. The amount of shares in the float will decide the price, just like $BMRN with only 4.5 million shares.
2 · Reply
BullsEye2000
BullsEye2000 Jul. 3 at 2:11 PM
$BMRN $85 break and this will be $100 today
0 · Reply
Latest News on BMRN
BioMarin Announces Completion of Acquisition of Inozyme

Jul 1, 2025, 8:45 AM EDT - 14 days ago

BioMarin Announces Completion of Acquisition of Inozyme

INZY


Why Is BioMarin Stock Trading Higher On Thursday?

Feb 20, 2025, 9:39 AM EST - 5 months ago

Why Is BioMarin Stock Trading Higher On Thursday?


BioMarin to Participate in Three Upcoming Investor Conferences

Nov 6, 2024, 8:00 AM EST - 8 months ago

BioMarin to Participate in Three Upcoming Investor Conferences


3 Oversold Stocks with Big RSI Rebound Potential

Oct 8, 2024, 2:42 PM EDT - 9 months ago

3 Oversold Stocks with Big RSI Rebound Potential

ELV HUM


Ascendis Challenges BioMarin, But Market Response Seems Excessive

Sep 17, 2024, 5:15 PM EDT - 10 months ago

Ascendis Challenges BioMarin, But Market Response Seems Excessive


BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time

Sep 4, 2024, 7:30 AM EDT - 11 months ago

BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time


BioMarin to reduce global workforce by about 225 employees

Aug 28, 2024, 5:32 PM EDT - 11 months ago

BioMarin to reduce global workforce by about 225 employees


BioMarin: Voxzogo Sales Surge Isn't Only Driving Force In 2024

Aug 21, 2024, 4:21 PM EDT - 11 months ago

BioMarin: Voxzogo Sales Surge Isn't Only Driving Force In 2024


BioMarin Announces New R&D and Business Development Leadership

Aug 21, 2024, 8:30 AM EDT - 11 months ago

BioMarin Announces New R&D and Business Development Leadership


BioMarin to Host 2024 Investor Day on September 4th in New York

Aug 19, 2024, 9:00 AM EDT - 11 months ago

BioMarin to Host 2024 Investor Day on September 4th in New York


Quantumup
Quantumup Jul. 14 at 4:24 PM
UBS reiterated $PTCT Buy-$71 after they hosted a medical geneticist and professor of pediatrics who is an expert on PKU and treats~320 patients. $BMRN $SRPT $JNJ $BIIB NVS RHHBY LRMR RARE VRTX EWTX CAPR #KOL UBS added, "Our discussion focused on the treatment paradigm in PKU with current management options (low-Phe diet, Kuvan/sapropterin, Palnynziq) as well as $PTCT's sepiapterin (recently approved in Europe as Sephience, US FDA PDUFA 7/29). Overall, we think the call was highly supportive of a strong potential launch for $PTCT's sepiapterin. UBS went on to give Their Key Takeaways from the Expert Call (In IMAGE Below):
0 · Reply
shoagh12
shoagh12 Jul. 9 at 6:16 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 9 at 8:33 AM
$BMRN Excellent article that nails exactly where BMRN stands right now. So if you want to update your BMRN knowledge or get acquainted with BMRN, this is a must read. https://beyondspx.com/article/biomarin-strategic-transformation-fuels-profitable-growth-trajectory-bmrn
0 · Reply
dewmoore
dewmoore Jul. 8 at 2:17 PM
$KNW Reposting for all of the newbies from $BMRN and $SBET --- $SRM -- STRIPE - BANK- STABLECOINS - CREDIT CARDS --- do the math TINY FLOAT and GREG giving us $100M+ in bitcoins --- shittt this is $BMNR alll day let's GO!!!!
0 · Reply
M1Tanker
M1Tanker Jul. 7 at 9:17 PM
$NCPL $BMRN 👇👇👇
1 · Reply
Stockbricks
Stockbricks Jul. 7 at 9:04 PM
$NCPL they looped in Matt Morgan to their advisory board, like $BNRN and NCSL is just shy of 25 mil. Imagine 200-500 market cap rise could head to 100 like $BMRN imo. I I’ll load slowly
0 · Reply
HodlMaBeer
HodlMaBeer Jul. 7 at 1:55 PM
@Pika_Capital what are your thoughts on $BMRN
0 · Reply
prohibited
prohibited Jul. 7 at 1:20 AM
These stocks are my favorites for tomorrow $OST , $SONN , $BMRN Is it 4 AM YET!?
0 · Reply
Codyz28
Codyz28 Jul. 4 at 3:11 AM
$SBET I've made money on both, but SBET has a lot more shares in the float now. It's the hard truth... It definitely will go up, but the $100 price range seems unlikely with the amount of shares it has now... $100 would be above 6 billion market cap. $BKKT has my vote to reach $100 first, has only 7 million shares in the float with 35 percent owned by insiders. This is why SBET stock was able to reach $100 due to the lower float size last month. The amount of shares in the float will decide the price, just like $BMRN with only 4.5 million shares.
2 · Reply
BullsEye2000
BullsEye2000 Jul. 3 at 2:11 PM
$BMRN $85 break and this will be $100 today
0 · Reply
PaulLaurent
PaulLaurent Jul. 3 at 2:09 PM
📊 10:10am EST RTH Update – July 3 $LIXT – Lixte Biotechnology closed a $5 million private placement, strengthening its cash position to support ongoing clinical programs. Keep on watch for continued momentum. $BMRN – Surged $20+ since the open, delivering major gains on strong follow-through. Continue to respect key levels. $WOLF – Jumped over 30% since 9:30am. One of today’s strongest runners after recent restructuring news. $RGC – Climbed over $8 from the open, extending its volatile multi-day run. Heavy volume pushing the tape. $OST – Bounced 46% off the lows, gaining traction as an oversold small cap reversal setup. ⚡ Mid-Morning Tone: Clear strength in biotech and turnaround names. High volatility remains—manage risk and ride momentum with discipline.
0 · Reply
MyFriendsCallMeMoe
MyFriendsCallMeMoe Jul. 3 at 9:23 AM
$BMRN Anyone care to give their bull and bear case?
0 · Reply
BearTamerTrading
BearTamerTrading Jul. 2 at 11:36 PM
1 · Reply
Eliza1
Eliza1 Jul. 2 at 7:31 PM
$BMRN Impressive gain this week and impressive hold. I love seeing shorts stopped out!
0 · Reply
SparkyReturns
SparkyReturns Jul. 2 at 2:46 PM
$MRNA Here's an Investing idea. Anyone remember when I gave this tip about ICU a few times in the last week...? Yeah. Just getting started. Expect a 10x +. $BMRN $ASND $VRNA $LLY
1 · Reply
bioebi
bioebi Jul. 1 at 7:52 PM
$NTIP $BMRN $BGLC $CLRO NTIP : getting ready for the firework
0 · Reply
giuseppe8469
giuseppe8469 Jul. 1 at 6:13 PM
$BMRN ions, tgtx, bmrn super good bios
0 · Reply
themacromindset
themacromindset Jul. 1 at 4:19 PM
$BMRN show us 80$
0 · Reply
HUSA_TO_100
HUSA_TO_100 Jul. 1 at 3:34 PM
$HUSA has smaller OS than $BMRN 🔥 Patiently waiting for it to hit TRIPLE DIGITS 💪
1 · Reply
SPYowl
SPYowl Jul. 1 at 3:14 PM
$BULL doing the same movements like $BMRN
0 · Reply
CallingStorms
CallingStorms Jul. 1 at 1:24 PM
$BMRN can anything save this or is she cooked?
0 · Reply
StockBraker
StockBraker Jul. 1 at 1:08 PM
$BMRN BioMarin Pharmaceutical announces completion of acquisition of Inozyme (INZY) As a result of the merger, all remaining Shares not tendered in the tender offer (other than Shares held by BioMarin and other than Shares held by Inozyme stockholders who are entitled and have properly demanded appraisal in connection with the merger under Delaware law) were converted into the right to receive $4.00 per share in cash, the same price that was paid in the tender offer. Following completion of the merger, the Shares have ceased trading on the Nasdaq Global Select Market and will be delisted.
0 · Reply